Stakeholders in National Surveillance
To carry out its infectious disease surveillance activities, Santé publique France relies on a network of partners in human and animal health.
National Initiatives for the Surveillance and Prevention of Healthcare-Associated Infections and Antibiotic Resistance
The national initiatives for the surveillance and prevention of healthcare-associated infections and antibiotic resistance were established in 2018 by a committee of experts. Their mandate and scope are renewed every 5 years. They cover the entire patient care pathway, whether in community care, medical-social facilities, or healthcare facilities. Led by Santé publique France, there are five such missions, which are grouped under REPIA (Network for the Prevention of Healthcare-Associated Infections). Learn more:
Three of these missions are particularly involved in monitoring bacterial resistance to antibiotics, monitoring antibiotic use, and promoting measures to prevent antibiotic resistance (barrier measures, appropriate antibiotic use).
- First: “ Surveillance and prevention of healthcare-associated infections and antibiotic resistance in community healthcare and the medical-social sector,” led by the CPias Pays-de-Loire in partnership with the CPias Auvergne-Rhône-Alpes, the CRAtb Pays-de-Loire, and the CRAtb Normandie.
- Spares: “Surveillance and Prevention of Antibiotic Resistance in Healthcare Facilities,” led by CPias Grand Est in partnership with CPias Nouvelle-Aquitaine, CRAtb Provence-Alpes-Côte d’Azur, and CRAtb Grand-Est.
- Matis: “Support for initiatives to prevent healthcare-associated infections and antibiotic resistance: assessment, training, communication, and documentation,” led by the CPias Nouvelle-Aquitaine in partnership with the CPias Iles de Guadeloupe.
National Reference Centers
Several missions assigned to the National Reference Centers make them key players in monitoring bacterial resistance to antibiotics and detecting the emergence and spread of new or rare forms of resistance.